術中神経モニタリングの世界市場：製品・サービス別、ソースタイプ別、用途別、最終用途別、地域別－予測分析（2022年～2028年）

世界の術中神経モニタリングの市場規模は、2021年の36億3,000万米ドルから2028年には46億1,000万米ドルに達すると予想され、2022年から2028年までの予測期間中のCAGRは4.53%になると予測されています。脳卒中、てんかん、アルツハイマー病、パーキンソン病、脳梗塞などの慢性疾患の発症率の上昇は、市場の成長を促進しています。

当レポートでは、世界の術中神経モニタリング市場について調査分析し、市場概要、市場規模、市場力学、企業プロファイルなど、体系的な情報を提供しています。

目次

エグゼクティブサマリー

市場概要

親市場分析

市場規模

• 市場力学
• 促進要因
• 機会
• 抑制要因
• 課題
• SWOT分析

主要な市場の洞察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料分析
• イノベーションマトリックス
• パイプライン製品分析
• マクロ経済指標

市場力学と展望

• 市場力学
• 促進要因
• 機会
• 抑制要因
• 課題
• 規制状況
• SWOT分析
• ポーター分析
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力
• 将来の混乱に関するSkyquestの特別な洞察
  • 政治的影響
  • 経済的影響
  • 社会的影響
  • 技術的影響
  • 環境的影響
  • 法的影響

世界の術中神経モニタリング市場：製品・サービス別

• 市場概要
• システム
• 付属品
• サービス

世界の術中神経モニタリング市場：ソースタイプ別

• 市場概要
• インソースモニタリング
• アウトソースモニタリング

世界の術中神経モニタリング市場：用途別

• 市場概要
• 脊椎外科
• 脳神経外科
• 血管手術
• 耳鼻咽喉科
• 整形外科

世界の術中神経モニタリング市場：エンドユーザー別

• 市場概要
• 病院
• 外来手術センター

世界の術中神経モニタリング市場規模：地域別

• 市場概要
• 北米
• 米国
• カナダ
• 欧州
• ドイツ
• スペイン
• フランス
• 英国
• その他の欧州
• アジア太平洋地域
• 中国
• インド
• 日本
• 韓国
• その他のアジア太平洋地域
• ラテンアメリカ
• ブラジル
• その他のラテンアメリカ
• 中東およびアフリカ
• GCC諸国
• 南アフリカ
• その他の中東

競合情勢

• トップ5選手比較
• 主要企業の市場ポジショニング（2021年）
• 主要な市場参入企業が採用した戦略
• 主要成功戦略
• 開発別
• 企業別
• 年別
• 市場における最近の活動
• 主要企業の市場シェア（%）（2021年）
• 主な企業プロファイル
• Medtronic（アイルランド）
• NuVasive（米国）
• Nihon Kohden（日本）
• Bovie Medical（米国）
• Natus Medical（米国）
• Checkpoint Surgical（米国）
• Magstim（英国）
• Inomed（ドイツ）
• Erbe Elektromedizin（ドイツ）
• Dr. Langer Medical（ドイツ）

Global Intraoperative Neuromonitoring market was valued at USD 3.63 billion in 2021, and is expected to reach a value of USD 4.61 billion by 2028, at a CAGR of 4.53% over the forecast period (2022-2028).

The market is expanding as a result of the increased focus on patient safety during challenging surgical procedures and the rising incidence of chronic illnesses such stroke, epilepsy, Alzheimer's disease, Parkinson's disease, and stroke. According to the WHO, neurological illnesses impact hundreds of millions of people globally. Worldwide, 15 million people experience a brain stroke each year. The market has expanded as a result of this.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intraoperative Neuromonitoring market and various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The Global Intraoperative Neuromonitoring Market is segmented based on product & service, source type, application, end-user, and region. Based on Product & Service it is categorized into Systems, Accessories, and Services. Based on Source Type it is categorized into Insourced Monitoring and Outsourced Monitoring. Based on Application it is categorized into Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, and Orthopaedic Surgery. Based on End-User it is categorized into Hospitals and Ambulatory Surgical Centres. Based on the region it is categorized into North America, Europe, Asia Pacific, South America, and MEA.

Driver

Neurological issues are common and are associated with prolonged hospitalizations in the intensive care unit (ICU) in critically ill COVID-19 patients receiving invasive mechanical ventilation, according to Frontiers Media S.A. in November 2020. Multimodal noninvasive neuromonitoring technologies were effective instruments for the early diagnosis of anomalies in cerebrovascular parameters during the pandemic. Additionally, more stringent patient education, recovery room assessment for non-ICU hospitalization, quicker mobilization, post-discharge communication, expanding acceptance of less invasive operations, and early post-imaging are all advised. Significant prospects for market expansion are anticipated as a result of these reasons.

Restraint

The intraoperative neuromonitoring market will be severely hampered by the high cost of IONM equipment and procedures. Depending on the number of channels, EEG devices with 1-32 channels can cost anywhere between US$ 1,000 and US$ 25,000, while those with more than 64 channels may cost more than US$ 25,000. Typically, portable amplifiers that can record EMG for longer than four hours cost around US$ 20,000. Many end users choose refurbished IONM devices over new ones due to financial restrictions because they provide significant cost savings. Refurbished IONM devices are sold by a number of businesses, including Alternative Source Medical. This decreases the demand for new IONM devices from well-known suppliers that make significant investments in R&D to create cutting-edge IONM devices. These elements are anticipated to restrict market expansion in

Market Trends

The prevalence of neurovascular illnesses is predicted to rise, increasing the demand for sophisticated intraoperative neuromonitoring devices and minimally invasive/noninvasive intraoperative neuromonitoring systems. Additionally, the majority of nations have begun to relax the rules on lockdowns and have resumed performing some elective surgery. The market is therefore anticipated to bounce back and expand during the forecast period. To deal with supply chain disruptions, businesses have been utilizing tactics like rerouting logistics, sourcing from extra partners, and air freight delivery. Major companies also want to geographically expand their operations and build more warehouses in various locations in order to conduct their business through the many accessible channels in the worst-affected areas and meet the rising demand.

These elements are anticipated to produce profitable expansion opportunities.

Table of Contents

Executive Summary

Market Overview

Wheel of Fortune

Research Methodology

Information Procurement

Secondary & Primary Data Sources

Market Size Estimation

Market Assumptions & Limitations

Parent Market Analysis

Market Overview

Market Size

Market Dynamics

Drivers

Opportunities

Restraints

Challenges

Key Market Insights

Technology Analysis

Pricing Analysis

Supply Chain Analysis

Value Chain Analysis

Ecosystem of the Market

IP Analysis

Trade Analysis

Startup Analysis

Raw Material Analysis

Innovation Matrix

Pipeline Product Analysis

Macroeconomic Indicators

Top Investment Analysis

Key Success Factor

Degree of Competition

Market Dynamics & Outlook

Market Dynamics

Drivers

Opportunities

Restraints

Challenges

Regulatory Landscape

Porters Analysis

Competitive rivalry

Threat of Substitute Products

Bargaining Power of Buyers

Threat of New Entrants

Bargaining Power of Suppliers

Skyquest Special Insights on Future Disruptions

Political Impact

Economic Impact

Social Impact

Technical Impact

Environmental Impact

Legal Impact

Global Intraoperative Neuromonitoring Market by Product & Services

Market Overview

Systems

Accessories

Services

Global Intraoperative Neuromonitoring Market by Source Type

Market Overview

Insourced Monitoring

Outsourced Monitoring

Global Intraoperative Neuromonitoring Market by Application

• Market Overview
• Spinal Surgery
• Neurosurgery
• Vascular Surgery
• ENT Surgery
• Orthopedic Surgery
• Global Intraoperative Neuromonitoring Market by End-User
• Market Overview
• Hospitals
• Ambulatory Surgical Center
• Global Intraoperative Neuromonitoring Market Size by Region
• Market Overview
• North America
• USA
• Canada
• Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
• By Development
• By Company
• By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021
• Key Company Profiles
• Medtronic (Ireland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• NuVasive (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Nihon Kohden (Japan)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Bovie Medical (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Natus Medical (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Checkpoint Surgical (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Magstim (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Inomed (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Erbe Elektromedizin (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Dr. Langer Medical (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments